Delivery Order SPE2DB22D3009-SPE2DB25FBF28
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Oxcarbazepine ER 600 mg tablets in quantities of 100 units, with a ceiling value of $3,449.47 and firm fixed pricing. This delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 1, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a continuation of the vendor's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine ER 600 mg tablets (100-count) on August 7, 2025, with a ceiling value of $12,813.16. This firm fixed price delivery order, which represents non-competitive procurement, is scheduled for completion by August 8, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded under the...
- The Defense Logistics Agency awarded a $34.77K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with an ultimate completion date of May 13, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,043.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Oxcarbazepine ER 600 mg tablets in quantities of 100 units. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of July 9, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a small-value pharmaceutical transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 150 mg tablets (100-count units) with a ceiling value of $2,169.26. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this qualified vendor. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count bottles) valued at $5,628.80 under a firm fixed-price contract structure. This non-set-aside delivery order represents a child contract against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $1,958.79 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,249.08 firm fixed-price delivery order is for the supply of OXCARBAZEPINE ER 600 MG TABLET 100S, a generic medication. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. The performance location is Conshohocken, PA. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250ml quantities, with a ceiling value of $1,442.97. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBF28Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count packaging) under a firm fixed-price contract valued at $7,215.32. The award, which must be completed by September 18, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC supports military healthcare systems globally by providing a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp's receipt of this neurology-focused medication order demonstrates its ongoing capability to fulfill federal medical supply requirements through competitive procurement channels and reinforces its role as a critical vendor within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/17/25 |